chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient within 5 minutes after receiving injection was being monitored and began to slump forward in the chair.  The patient quickly became completely unconscious and was helped to the floor.  The patient was presenting with seizure like symptoms, foaming at the mouth and loss of body functions.  Patient remained unconscious for 1 minute or less before regaining consciousness.  He was able to speak immediately after.  Patient had a rapid heart rate and was sweating.  Patients blood pressure was elevated as well.  Patients blood sugar was tested and was 146.  911 was called immediately at time of emergency and when they arrived they help that patient sit up.  They took the patient to the emergency room since he did not immediately regain all functions and this vitals remained elevated.
Information has been received from a physician concerning a 64 year old female with immunodeficiency who was vaccinated with two dose of PNEUMOVAX 23 without sero-converting. Physician also mentioned the patient received PREVNAR with no seroconversion. Additional information is not expected.
Shooting Pain from shot site to shoulder to neck and back again, started Friday and has gotten progressively worse.  Icing areas in pain is all I have done as treatment, scheduled an appointment for tomorrow with my primary care physician
Very heavy clotting menstruation for 3 cycles, then each menstrual cycle became shorter in duration (previously every 28 days, then 26 days, then 23 days, now every 21 days).
Immediately after Gardasil shot #2 administered patient became dizzy, nauseous and had a vasovagal reaction lasting few minutes.  Monitored by Dr. and discharged from our office to home.
Vomiting, nausea, diarrhea, shivering, fatigue, headache, increased heart rate.
Received half dose booster instead of a full dose repeat; This spontaneous case was reported by a physician and describes the occurrence of ACCIDENTAL UNDERDOSE (Received half dose booster instead of a full dose repeat) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Stem cell transplant (Took after Moderna second dose.) on 01-Apr-2021.    On 17-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 17-Nov-2021, the patient experienced ACCIDENTAL UNDERDOSE (Received half dose booster instead of a full dose repeat). On 17-Nov-2021, ACCIDENTAL UNDERDOSE (Received half dose booster instead of a full dose repeat) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant information was not provided.  It was reported that patient was instructed by MD to repeat the doses after stem cell transplant but HCP gave her a half dose booster instead of repeating full dose.  Treatment information was not provided.   This case was linked to MOD-2021-403091 (Patient Link).
Patient continues to experience left arm pain since first Pfizer vaccine given 3/6/2021, pain is sharp when raises arm, no further information available
"severe" rxn to flu shot on 11NOV95 c/o sore throat, & felt awful, fever, draggy feeling,vomiting, h/a, bronchitis type cough, nasal draining (lots);cont until 14NOV95; pt is convinced above sxs from flu vax
Dizziness, numbness in face, tongue, and throat feeling tight.  4:00 PM  Vital Signs: BP 116/78 HR 40 O2Sat 97%  Skin Signs: Diaphoretic, Other - Cool fingers  Circulation: Cap Refill <2sec  Respiratory: Breath sound clear bilaterally  Initial Treatment:  Approx 10 min after vaccine, tongue and lips began to feel slightly numb. Briefly a little dizzy, but that soon passed. Taken to triage at 4:05 PM when numbness increased.  4:15 PM Vital Signs: BP 124/76 HR 66 O2Sat 98%  Skin Signs: Cool and dry  Circulation: Cap refill <2sec  Respiratory: Breath sound clear bilaterally  4:30 PM Vital Signs: HR 69 O2Sat 96%  Skin Signs: Cool and dry  4:40 PM  Vital Signs: BP 130/78 HR 67 O2Sat 99%  Notes:  Decision made to call husband to transport to hospital. Face and tongue feeling worse. 5:00 PM Vital Signs: BP 132/80 HR 62 O2Sat 99%  Sent to ER with husband 5:10 PM 04/14/2021: 11:45 AM: Follow up phone call to patient. Doing very well today. Stated she was observed in ER for 1 hour last night. Symptoms gradually subsided over 4 hours. No treatment needed.
4/21/2021   Pt was observed post Covid-19 immunization for 15 minutes .  During the observation period, she experienced an adverse reaction with the following symptoms:  dizziness, weakness and low blood sugar.   Assessment : Time of assessment 113pm. Alert and oriented, Anxious and Diaphoretic.   Actions taken:  Vitals sign taken  form obtained and completed by RN. VS at 113pm BP- 152/81, P- 68, O2- 98%. Recheck at 128pm, BP- 102/65, P- 69, O2- 100%, Recheck at 140pm, BP- 136/65, P- 68, O2- 100%. Juice given x 2, Fan place on patient to circulate air.       Medications administered: none   Disposition: Reports no further symptoms of adverse reaction after observation for 30 minutes. Discharged home. The Patient was provided with Vaccine Information Sheet and instruction to access the system.      Immunizations Administered    Name Date Dose VIS Date Route   Pfizer COVID-19 Vaccine 4/21/2021  1:10 PM 0.3 mL 2/25/2020 Intramuscular   Manufacturer: Pfizer, Inc
The patient stated she experienced fatigue, nausea and vomiting hours after receiving the vaccine. She ultimately ended up going to the emergency room and was treated with Zofran.
Fever and overtired on day 8. Hives all over leg, some on arm and face on day 10-11. (still continuing as of the date of this report). Day 10 hives responded well to Claritin 5mg prescribed by her pediatrician. Day 11 hives is more stubborn. Still visible after Claritin 5mg as of this report.
Information has been received from a consumer concerning her 15 month old son with no pertinent medical history and no drug reactions or allergies, who in approximately September 2008, was vaccinated with a dose of MEASLES virus vaccine (Enders-Edmonston). Concomitant therapy included PREVNAR. The child's mother reported that she remembered measles virus vaccine live (Enders-Edmonston) was given at 15 months of age and experienced a fever of 104F for 3 days, then on the 12th day after vaccination a high fever again for 3 days. The child also experienced moodiness after receiving the vaccine. At time of reporting, the patient had recovered. The patient sought medical attention as his mother called the office. There were no lab or diagnostic studies performed. The consumer also reported that the patient experienced an adverse event with rubella virus vaccine live (HPV-77) (WAES#0902USA02199) and VARICELLA virus vaccine live (Oka/Merck) (WAES# 0902USA02200). Follow-up information received on 27-FEB-2009 from a physician stated that the patient received the first dose of measles virus vaccine live (Enders-Edmonston) on 21-OCT-2008 (lot # 654623/0034U), subcutaneously. The patient received the first dose of HAVRIX (lot # AHAVB297CA) intramuscularly into the right deltoid on 07-OCT-2008. The reporter stated that the patient did not call or had an office visit after the vaccine adverse effect. No laboratories studies performed, no illness at time of vaccination. At the time of this report, the patient had recovered on an unspecified date. No further information is available.
Inflammation and radiating heat following the lymphatic vessels from the injection site for approximately 3 to 4 inches.
Suspect vaccination failure; I did get both shots./Caught it early bit did get a mild case recently; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The case reported by the patient herself/himself. The age at vaccination was not reported. The patient stated that he/she got the both shot of Shingles vaccine and had shingles. The patient stated that guess what he/she caught it early bit and did get a mild case recently. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting.
Vaccination site itcy; injection site was firm; rash; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PRURITUS (Vaccination site itcy), VACCINATION SITE INDURATION (injection site was firm) and VACCINATION SITE RASH (rash) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history).    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Vaccination site itcy), VACCINATION SITE INDURATION (injection site was firm) and VACCINATION SITE RASH (rash). The patient was treated with PHENOXYMETHYLPENICILLIN POTASSIUM (PENCILLIN) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (Vaccination site itcy), VACCINATION SITE INDURATION (injection site was firm) and VACCINATION SITE RASH (rash) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no concomitant medication provided.
drive through setup, within minutes after injection, began to feel tingling in forehead which moved down my body.  Between 5-10 minutes after injection, I just passed out (don't recall that happening).  Woke to 2 EMT's by my side asking to check my blood pressure..  I don't recall the numbers however they stated I 'bottomed out'.  shortly after gaining consciousness, I became nausea loosing contents of stomach twice.  Remained under observation for 30+ minutes, then wife drove me home.  Slept until 5:00 when I was steady enough to walk unaided, and finally eat some dinner.
Within 2-3 minutes after giving vaccines site of MMR (L.V.L.) immediately red & within 5-6 min hive like blotch about 2" x 3" to area going toward back of leg. Provider notified & ice applied. No resp distress. Gave12mg BENADRYL orally but vomited it up right away with cough & crying. Monitored for 20 min & area of redness decreased to about 1 inch. No hive.
Sore left arm; Fatigue; Swollen lymph nodes under left arm and along left clavicle; This is a spontaneous report received from a contactable consumer, the patient. A 42-year-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6199) via an unspecified route of administration on left arm on 23Mar2021 at 10:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history, however, she was allergic to milk and gluten sensitivity. The patient did not receive any other medications within two weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN5318) via an unspecified route of administration on the left arm on 02Mar2021 at 09:45 (at the age of 42-year-old), as single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 24Mar2021 at 10:30 The patient experienced sore in the left ram, fatigue and swollen lymph nodes under left arm and along left clavicle on. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events sore in the left ram, fatigue and swollen lymph nodes were resolving at the time of reporting.   No follow-up attempts are needed. No further information expected.
Swelling, redness and tenderness in knees bilaterally.  Noted several days after the vaccine was given.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and unknown gender. Patient's concurrent conditions and relevant medical history was not reported. On 03-FEB-2015, the patient was vaccinated with MMR II (lot number: K002816  with unspecified expiration date) (dose, frequency and route unspecified) that had underwent temperature excursion. Concomitant medications were not reported. No adverse effects were reported. The outcome of the events was unknown. The causality of the events with MMR II was not reported. Product quality issue was not involved. This is one of the several reports from the same reporter. Additional information has been requested.
Itching and vomitting.  Received BENADRYL, PEPCID & Solu-Medrol in the Emergency Dept of the hospital. Severe vomiting, itching all over.
Approximately 10 minutes after vaccination, patient reported feeling shakiness.  Patient was provided with water and chocolate candy as patient seemed to be exhibiting pre-syncopal symptoms.  Continued to monitor for 20 additional minutes.  Patient still reported shakiness as well as nausea and electrical shocks up back.
Red & swelling developed 6 hours after vaccine given - progressively worse (larger & increased itching).
Patient experienced severe vomiting after receiving Rotateq. Advised by provider to discontinue further doses.
mild headache within hour of administration of vaccination. Fatique/malaise. foggy head.
01/10/2022: 90-year-old female who presents to the ED with chief complaint of positive COVID-19 test.  Reportedly the patient lives in a care center.   she is asymptomatic and the test was a routine screening test due to exposure.
Patient came to local pop up vaccine clinic that was being hosted at his school. At the time of vaccination, he had received a single dose of the monovalent Pfizer COVID-19 vaccine therefore he had not completed his primary series. He inadvertently received the bivalent vaccination at the clinic instead of completing his primary series. He was monitored for 15 minutes after. He did not display any adverse reactions. We contacted our Medical Director, concerning the matter. He did not recommend the child complete his primary series or receive any other vaccine at this time. He recommended to re-evaluate when/if another booster dose becomes available to the public.
3RD DOSE MODERNA COVID VACCINE GIVEN 12/10/2021, #030H21B; 4TH DOSE MODERNA COVID VACCINE GIVEN 4/19/22, #004321A.  pt admitted to hospital with worsening SOB and hypotension; required intubation and mechanical ventilation; positive for COVID; condition worsened; DNR; eventually transitioned to comfort measures and passed away in the hospital
During administration of vaccine, the patient stated he was feeling dizzy. His skin became pale at that time. The LVN layed him down on the exam table and got him a wet rag for his forehead. He stated he was feeling better after a minute had passed. LVN advised him to continue to lay flat with feet up while she went to get the provider to assess him before he left. When NP & LVN returned to the room the patient's mother was standing beside him by the exam table. NP & LVN observed what is believed to be a seizure. The NP activated 911. Vitals repeated while waiting on EMS, all vitals WNL. No other episodes witnessed in clinic. EMS took patient to nearest ER.
Diarrhea/streaks of blood in feces; A spontaneous report was received from a consumer concerning for himself, a 47-year-old male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced event Diarrhea/streaks of blood in feces/ Diarrhoea haemorrhagic.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 12Mar2021, prior to the onset of the event, the patient received his planned dose of mRNA-1273 (lot/batch 027A21A), intramuscularly, for prophylaxis of COVID-19 infection.  On 15Mar2021, the patient experienced diarrhea and streaks of blood in feces.   Action taken with mRNA-1273 in response to the events was unknown.  The outcome of the events, Diarrhea/streaks of blood in feces was considered as unknown at the time of the report.; Reporter's Comments: Based on the current limited available information provided at this time and lack of temporal association between the use of the product and the start date of the event, Diarrhea Hemorrhagic, the event was assessed as possibly Related to study drug.
Fatigue, swollen lymph nodes, mild pain in different parts of body; right shoulder, right hip, left side of abdomen, and mild headache with second dose. Herpes outbreak episode with both vaccines within a week of being vaccinated.
Information has been received from a registered nurse referring to 2 unspecified patients of unknown age and gender. The patients' medical history, concurrent condition and concomitant medication were unknown. On unspecified dates, the patients were vaccinated with improperly stored PNEUMOVAX 23 (dose and route unknown, lot # L019835, expiration date: 23-MAR-2017). No adverse effects were reported. This is one of three reports received from the same reporter. Additional information has been requested.
pt was given 0.5mL of Moderna Bivalent instead of correct dose of 0.25ml 12-9-22, called and spoke with patient mom, patient mom reported pain at injection site and patient was tired/slept all evening last night. -Denies symptoms of fever, dizziness, headaches, cough, shortness of breath, or fatigue today.  Patient mom reports he is doing ok.
DIZZINESS; FELT SLEEPY; MODERATE HEADACHE; NAUSEA; FELT TIRED; FEVER; BODY ACHES; MILD BONE PAIN; SENSITIVITY TO NOISE; NERVES ON NECK FEEL VERY TENSE; This spontaneous report received from a patient concerned a 45 year old female. The patient's past medical history included covid-19 infection, and concurrent conditions included high blood pressure, hypothyroidism, low vitamin d level, non smoker, and non alcohol user, and other pre-existing medical conditions included the patient had no drug or non-drug allergies. the patient did not have any history of drug abuse or illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1808980 expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, the subject experienced sensitivity to noise. On APR-2021, the subject experienced nerves on neck feel very tense. On 10-APR-2021, the subject experienced body aches. On 10-APR-2021, the subject experienced mild bone pain. On 10-APR-2021, the subject experienced felt tired. On 10-APR-2021, the subject experienced fever. On 11-APR-2021, the subject experienced dizziness. On 11-APR-2021, the subject experienced felt sleepy. On 11-APR-2021, the subject experienced moderate headache. On 11-APR-2021, the subject experienced nausea. On 13-APR-2021, treatment medications included: caffeine/paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from moderate headache, and the outcome of body aches, fever, mild bone pain, felt tired, nausea, dizziness, felt sleepy, sensitivity to noise and nerves on neck feel very tense was not reported. This report was non-serious.
Injection given 1/4/2021. reaction started on 1/12/2021 around 4:30 p.m.- noticed itching in area where injection was given. Later that evening noticed a large swollen  red area where injection had been given that was itchy. Called site where vaccination was given- was told to see general physician if symptoms continue or spread. Spoke w/ a dermatologist who recommended taking antihistamine and apply hydrocortisone to area. Also noticed on 1/13/2021 that hands felt slightly swollen and lips felt swollen and hurt. After starting antihistamine lips and hands felt better. 1/14/2021 called family physician- told to continue with antihistamine and hydrocortisone and to call if does not clear up or spreads.
Severely painful joints (knees and back), light-headed when I tried to work out a few days later.  Rash developed along the spine on the back of my neck.  2  weeks after first shot, my heart began to hurt -- sharp pains, followed by a feeling that there was pressure on it.  It would come and go for several days.  I have NEVER felt anything like that before and my doctor tells me my heart is in good health.   This happened again after my second shot.
I woke up with very sore legs.  Upon rubbing them I felt large swellings on the outer sides of both lower legs.  General swelling went from knee to ankle, but gross swelling appeared in the two areas mentioned.  They were very sore, and it was uncomfortable to walk.  I got up and showered and moved my legs around and got on my stationery bicycle to increase the blood flow.  But these areas remained swollen for 3 days, and the general swelling for 2 weeks.  I have never had any experience like this,  or any such swelling.
Information has been received from the mother of a 3 year old female patient who on approximately 11/26/02 was vaccinated with a dose of varicella virus vaccine live. That same day, approximately 11/26/02, the patient was concomitantly vaccinated with a dose of influenza virus vaccine. No other concomitant medications or concurrent conditions were noted. Subsequently, the patient was losing her ability to walk, had weakness on the right side of the body, was unable to sleep at night, developed some coughing and was digging at her ear as if she had pain. Unspecified medical attention was sought. According to the mother, the patient was getting worse. At the time of this report, the patient was to be seen by a neurologist. Upon internal review, the patient's abasia was considered an other medical event (OMIC). Additional information has been requested.
MMR given 11/6/03; approx 11/29/03 seen in ER with rash; 12/8/03 saw Dr and maculopapular rash, c/o low grade fever and feeling tired. CBC+CMP done. Bland creams and Atarax.
6:30pm, given vaccine right deltoid. 1 hour later felt fevered and arm pain. Increasing pain/heat/swelling arm overnight. Pain deltoid and gradually in axilla as well by 18 hour from injection. No erythema per pt. Exam 3 hives overlying injection site-fait pink/roused 1-2 cm, increasing heat, swelling deltoid 4 inches and tender entire upper deltoid and tender superior biceps and upper medial arm into axilla.  Mild nausea, temperature 99, no shortness of breath.
Information has been received from a registered nurse referring to a 27 year old patient of unknown gender. On 11-MAR-2015 the patient was supposed to receive the second dose of VARIVAX (Merck) but instead received a dose of ZOSTAVAX (subcutaneous, lot# and dose were not reported). No symptoms were reported. Additional information has been requested.
No s/s at present. Wrong vaccine type given to patient - pediatric dose vs adult dose.